09:22 AM EST - Oncolytics Biotech Inc : Announced the closing of the previously announced underwritten public offering of US$15,000,750. An institutional investor was a significant participant in the Offering. The Company intends to use the proceeds from the Offering to continue the advancement of its pelareorep clinical programs in metastatic breast and pancreatic cancers, as well as general corporate and working capital purposes. Oncolytics Biotech Inc
shares T.ONC are trading unchanged at $2.81.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=7803544959868011
